Trans-Sobrerol

Trans-Sobrerol (NRM-331) is a potent mucofluidifying agent. trans-Sobrerol demonstrates an anti-amnesic effect by enhancing hippocampal cholinergic signaling, alongside exhibiting anti-tau and anti-Aβ synthesis properties. trans-Sobrerol mitigates memory impairment induced by Scopolamine. trans-Sobrerol can be used in the research of Alzheimer's disease[1][2].

Product Specifications

CAS Number

42370-41-2

Product Name Alternative

NRM-331

UNSPSC

12352211

Hazard Statement

H315-H319-H335

Target

Amyloid-β; Tau Protein

Related Pathways

Neuronal Signaling

Field of Research

Neurological Disease

Smiles

[C@@](C)(C)(O)[C@H]1C[C@H](O)C(C)=CC1

Molecular Formula

C10H18O2

Molecular Weight

170.25

Precautions

P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P362-P403+P233-P405-P501

References & Citations

[1]Ansari A, et al. Sobrerol Improves Memory Impairment in the Scopolamine-Induced Amnesia Mouse Model. Int J Mol Sci. 2025 May 12;26 (10) :4613. |[2]Ventura P, et al. The metabolism of trans-sobrerol in the rat. Xenobiotica. 1983 Mar;13 (3) :139-46.